Accession Number: | 0001209191-20-042500 |
Date: | 2020-07-14 |
Issuer: | POSEIDA THERAPEUTICS, INC. (PSTX) |
Original Submission Date: |
MURPHY SEAN
C/O POSEIDA THERAPEUTICS, INC.
9390 TOWNE CENTRE DRIVE, SUITE 200
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-14 | C | 7,013,918 | a | $0.00 | 7,013,918 | indirect | ||
COMMON STOCK | 2020-07-14 | C | 1,168,985 | a | $0.00 | 8,182,903 | indirect | ||
COMMON STOCK | 2020-07-14 | C | 690,124 | a | $0.00 | 8,873,027 | indirect | ||
COMMON STOCK | 2020-07-14 | C | 315,098 | a | $0.00 | 9,188,125 | indirect | ||
COMMON STOCK | 2020-07-14 | P | 10,000 | a | $16.00 | 10,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SERIES A PREFERRED STOCK | 0.0 | 2020-07-14 | deemed execution date | C | 8,746,356 (d) | common stock 7,013,918 | $0.00 | 0 | indirect | see footnote | ||
SERIES A-1 PREFERRED STOCK | 0.0 | 2020-07-14 | deemed execution date | C | 1,457,725 (d) | common stock 1,168,985 | $0.00 | 0 | indirect | see footnote | ||
SERIES B PREFERRED STOCK | 0.0 | 2020-07-14 | deemed execution date | C | 860,585 (d) | common stock 690,124 | $0.00 | 0 | indirect | see footnote | ||
SERIES C PREFERRED STOCK | 0.0 | 2020-07-14 | deemed execution date | C | 392,927 (d) | common stock 315,098 | $0.00 | 0 | indirect | see footnote |
ID | footnote |
---|---|
f1 | each share of the issuer's series a preferred stock, series a-1 preferred stock, series b preferred stock and series c preferred stock (collectively, the "preferred stock") automatically converted into 0.8019246 shares of the issuer's common stock upon the closing of the issuer's initial public offering. the preferred stock had no expiration date. |
f2 | represents shares of common stock issuable upon conversion of preferred stock held by malin holdings, a wholly owned subsidiary of malin corporation plc ("malin"), and may be deemed to be beneficially owned by malin. malin may be deemed to share voting and investment power over securities held by malin holdings. mr. murphy currently serves as a member of the leadership team at malin. the reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of section 16 or for any other purpose. |